ENANTA PHARMACEUTICALS INC (ENTA)
US29251M1062 - Common Stock
| TTM (2023-12-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -138.24M | -133.82M | -121.76M | -79.00M | -36.17M | |||
| Depreciation Amortization | 2.50M | 2.37M | 2.97M | 3.33M | 3.64M | |||
| Income Taxes - Deferred | N/A | 0.00 | 0.00 | 350.00K | 10.61M | |||
| Change In Working Capital | 20.61M | 8.02M | 6.79M | -13.69M | 12.90M | |||
| Taxes Paid | N/A | 4.90M | 0.00 | 30.00K | 110.00K | |||
| Other non cash items | 22.63M | 20.27M | 27.21M | 19.01M | 16.10M | |||
| OPERATING CASH FLOW | -92.50M | -103.15M | -84.78M | -70.00M | 7.09M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -6.69M | -9.06M | -2.13M | -750.00K | -1.45M | |||
| Other Investing Activity | -93.58M | -44.52M | 57.02M | 37.74M | 21.28M | |||
| INVESTING CASH FLOW | -100.27M | -53.58M | 54.90M | 36.99M | 19.83M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 1.08M | 2.21M | 21.26M | 3.61M | 10.48M | |||
| Other Financing Activity | 189.40M | 195.92M | -1.23M | -530.00K | -1.50M | |||
| FINANCING CASH FLOW | 190.48M | 198.13M | 20.03M | 3.08M | 8.98M | |||
| CHANGE IN CASH | -2.29M | 41.40M | -9.85M | -29.93M | 35.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -92.50M | -103.15M | -84.78M | -70.00M | 7.09M | |||
| Capital Expenditure | -6.69M | -9.06M | -2.13M | -750.00K | -1.45M | |||
| FREE CASH FLOW | -99.19M | -112.21M | -86.91M | -70.75M | 5.64M | |||
All data in USD